Efficacy of lamivudine in treatment on HBV-related liver failure：Meta analysis study

张耀; 郑莎; 周吉军; 王宇明

您当前的位置：

首页 >

文章列表页 >

Efficacy of lamivudine in treatment on HBV-related liver failure：Meta analysis study

更新时间：2026-01-09

- Efficacy of lamivudine in treatment on HBV-related liver failure：Meta analysis study
- Journal of Army Medical University Vol. 30, Issue 9, Pages: 848-850(2008)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC： R195.4;R575.305;R978.7
- Published：2008
- 稿件说明：
移动端阅览
张耀,郑莎,周吉军,王宇明.拉米夫定治疗乙型肝炎病毒相关性肝衰竭疗效的Meta分析[J].陆军军医大学学报(原第三军医大学学报),2008,30(09):848-850.

　ZHANG Yao,ZHENG Sha,ZHOU Ji-jun,WANG Yu-ming.Efficacy of lamivudine in treatment on HBV-related liver failure：Meta analysis study[J].J Amry Med Univ (J Third Mil Med Univ),2008,30(09):848-850.
张耀,郑莎,周吉军,王宇明.拉米夫定治疗乙型肝炎病毒相关性肝衰竭疗效的Meta分析[J].陆军军医大学学报(原第三军医大学学报),2008,30(09):848-850. DOI：

　ZHANG Yao,ZHENG Sha,ZHOU Ji-jun,WANG Yu-ming.Efficacy of lamivudine in treatment on HBV-related liver failure：Meta analysis study[J].J Amry Med Univ (J Third Mil Med Univ),2008,30(09):848-850. DOI：

摘要

目的系统评价拉米夫定治疗乙型肝炎病毒（HBV）相关性肝衰竭的疗效。方法检索1989年1月至2007年7月有关在常规内科治疗的基础上加用拉米夫定后对患者病死率、总胆红素（TBIL）及凝血酶原活动度（PTA）影响的文献，应用Meta分析的方法以比值比(OR)或加权平均数（WMD）为效应量进行合并分析。结果上述研究指标纳入研究文献分别为13、10篇和10篇，合并效应量及95%可信限（95% CI）分别为0.29（95％CI：0.21，0.40）、-0.88（95％CI：-1.27，-0.48）和0.60（95％CI：0.42，0.78）。结论与常规内科治疗组比较，加用拉米夫定可以显著降低肝衰竭患者的病死率，改善患者的TBIL和PTA水平。

Abstract

Objective To evaluate the therapeutic effect of lamivudine in the treatment of HBV-related liver failure. Methods We collected the literature on lamivudine used to treat liver failure in randomized control trail or clinical control trial studies from January 1989 to July 2007. All these clinical trials were carried out by comparing lamivudine treatment with routine medical treatment for liver failure. The literature must concern about mortality

total bilirubin (TBIL) or prothrombin activity (PTA). Odds ratio (OR) was applied to evaluate the effect of glucocorticoid to improve case fatality. Weighted mean differences (WMD) was applied to evaluate the effect of lamivudine to improve TBIL and PTA. Results There were only 13 literatures obtained

among them all about mortality

and 10 about TBIL and PTA. Effective index was 0.29 (95％CI: 0.21

0.40)

-0.88 (95％CI: -1.27

-0.48) and 0.60 (95％CI: 0.42

0.78) respectively for the 3 indexes. Conclusion Combination with lamivudine is more effective in treatment liver failure than only routine medical treatment.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effect of lamivudine on survival rate of patients with chronic severe hepatitis B

A novel estrogen receptor expression stratification (low/moderate/high) based on Chinese population provides more accurate prognosis prediction for HR⁺/HER2^- early breast cancer patients

Immunosuppressive microenvironment of TGIF1-overexpressing gastric cancers and its clinical significance

Impact of molecular heterogeneity of NPM1 mutations on prognosis of acute myeloid leukemia: a clinical report of 86 cases

Association of 5-factor modified frailty index and controlling nutritional status score with overall survival in patients with unresectable hepatocellular carcinoma undergoing interventional therapy

Related Author

张南

夏杰

邓国宏

王宇明

WANG Chengfang

ZHOU Yuqin

ZHANG Yanling

QI Xiaowei

Related Institution

Department of Breast and Thyroid Surgery， First Affiliated Hospital， Army Medical University （Third Military Medical University）

Department of Gastroenterology， Chongqing Hechuan District People’s Hospital

School of Medicine， Chongqing University

Chongqing Key Laboratory of Precision Prevention and Treatment for Digestive System Tumors， Department of Gastroenterology， Army Medical Center of PLA/Daping Hospital of Third Military Medical University

Department of Hematology, the First Hospital of Lanzhou University

⁰